{
    "timestamp": "Mar 10, 2025 8:45 AM EST",
    "stats": {
        "input_words": 274178,
        "output_words": 587,
        "filings_processed": 8
    },
    "filings": [
        {
            "company_name": "Alliant Energy",
            "stock": "LNT",
            "wiki_url": "https://en.wikipedia.org/wiki/Alliant_Energy",
            "change_percent": 0,
            "price": 62.49,
            "filing_type": "8-K",
            "filing_time": "2025-03-10T08:35:37-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/352541/000035254125000029/0000352541-25-000029-index.htm",
            "accession_number": "0000352541-25-000029",
            "summary_points": [
                "1. John O. Larsen will retire as Chairman of the Board of Alliant Energy Corporation, Interstate Power & Light Company, and Wisconsin Power & Light Company after the 2025 Annual Meeting of Shareowners.",
                "2. Patrick E. Allen, a board member since 2011, has been designated as the new Board Chair, effective after the 2025 Annual Meeting of Shareowners.",
                "3. This 8-K filing, dated March 7, 2025, reports the departure of a director and the appointment of a new chair; no other significant developments or risks are mentioned."
            ]
        },
        {
            "company_name": "Dexcom",
            "stock": "DXCM",
            "wiki_url": "https://en.wikipedia.org/wiki/Dexcom",
            "change_percent": 0,
            "price": 77.85,
            "filing_type": "8-K",
            "filing_time": "2025-03-10T08:31:23-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1093557/000109355725000050/0001093557-25-000050-index.htm",
            "accession_number": "0001093557-25-000050",
            "summary_points": [
                "1. On March 6th, 2025, DexCom, Inc. appointed Ren\u00e9e Gal\u00e1 as a director to its eleven-member board.",
                "2. Ms. Gal\u00e1 received an initial equity grant of restricted stock units (RSUs) valued at $500,000, vesting annually over three years, plus a pro-rata annual grant of RSUs worth $56,986.",
                "3.  A change in control of DexCom would trigger full and immediate vesting of outstanding equity awards held by non-employee directors."
            ]
        },
        {
            "company_name": "Cincinnati Financial",
            "stock": "CINF",
            "wiki_url": "https://en.wikipedia.org/wiki/Cincinnati_Financial",
            "change_percent": 0,
            "price": 140.03,
            "filing_type": "8-K",
            "filing_time": "2025-03-10T08:28:26-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/20286/000002028625000015/0000020286-25-000015-index.htm",
            "accession_number": "0000020286-25-000015",
            "summary_points": [
                "1. Cincinnati Financial's 2024 Property and Casualty premium growth of 13% significantly exceeded its 15-year CAGR of 8%.",
                "2.  The company's 2024 combined ratio was 96.5%, which included $26 million in net unfavorable reserve development.",
                "3.  Cincinnati Financial projected a 6% to 10% increase in Property and Casualty premiums for 2025,  a prediction made in March 2022."
            ]
        },
        {
            "company_name": "Diamondback Energy",
            "stock": "FANG",
            "wiki_url": "https://en.wikipedia.org/wiki/Diamondback_Energy",
            "change_percent": 0,
            "price": 140.04,
            "filing_type": "8-K",
            "filing_time": "2025-03-10T08:15:42-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1539838/000114036125007771/0001140361-25-007771-index.htm",
            "accession_number": "0001140361-25-007771",
            "summary_points": [
                "1. Diamondback Energy, Inc. entered into an Underwriting Agreement on March 6, 2025, to issue $1,200,000,000 of 5.550% Senior Notes due 2035, with an expected closing on March 20, 2025.",
                "2. The net proceeds from the note sale are expected to be approximately $1.19 billion,  a portion of which will fund the pending acquisition of Double Eagle subsidiaries.",
                "3.  The Underwriting Agreement includes customary representations, warranties, covenants, indemnification, and contribution provisions."
            ]
        },
        {
            "company_name": "Emerson Electric",
            "stock": "EMR",
            "wiki_url": "https://en.wikipedia.org/wiki/Emerson_Electric",
            "change_percent": 0,
            "price": 118.56,
            "filing_type": "8-K",
            "filing_time": "2025-03-10T07:11:17-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/32604/000114036125007760/0001140361-25-007760-index.htm",
            "accession_number": "0001140361-25-007760",
            "summary_points": [
                "1. Emerson Electric Co. extended the deadline for its tender offer to acquire Aspen Technology, Inc. to 5:00 p.m., Eastern Time on March 11, 2025.",
                "2.  The initial tender offer price was $265 per share.",
                "3. The acquisition is subject to several conditions, including at least a majority of AspenTech's outstanding shares being tendered, and the possibility of competing offers or government intervention poses risks to the transaction's completion."
            ]
        },
        {
            "company_name": "Cardinal Health",
            "stock": "CAH",
            "wiki_url": "https://en.wikipedia.org/wiki/Cardinal_Health",
            "change_percent": 0,
            "price": 126.49,
            "filing_type": "8-K",
            "filing_time": "2025-03-10T06:53:45-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/721371/000072137125000020/0000721371-25-000020-index.htm",
            "accession_number": "0000721371-25-000020",
            "summary_points": [
                "1. On March 7, 2025, Cardinal Health, Inc. added Robert Musslewhite and Sudhakar Ramakrishna to its Board of Directors.",
                "2.  Both new board members have extensive experience leading technology companies; Musslewhite in healthcare and Ramakrishna in broader technology.",
                "3.  The compensation for the new directors will be consistent with that of other non-employee directors, as detailed in the company's 2024 Schedule 14A proxy statement."
            ]
        },
        {
            "company_name": "Insulet Corporation",
            "stock": "PODD",
            "wiki_url": "https://en.wikipedia.org/wiki/Dexcom",
            "change_percent": 0,
            "price": 251.92,
            "filing_type": "8-K",
            "filing_time": "2025-03-10T06:35:24-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1145197/000114519725000011/0001145197-25-000011-index.htm",
            "accession_number": "0001145197-25-000011",
            "summary_points": [
                "1. Insulet Corporation and NXP USA, Inc. amended their Purchase Agreement on March 7, 2025, extending its term and modifying pricing, volume, warranties, and product modifications.",
                "2.  The amendment, effective January 1, 2025, covers purchases from January 1, 2025, to December 31, 2025, with purchase orders already placed for the first two quarters of 2025.",
                "3.  Significant portions of the Addendum to the Purchase Agreement are redacted as confidential, limiting the full understanding of the agreement's details."
            ]
        },
        {
            "company_name": "Cencora",
            "stock": "COR",
            "wiki_url": "https://en.wikipedia.org/wiki/Cencora",
            "change_percent": 0,
            "price": 254.5,
            "filing_type": "8-K",
            "filing_time": "2025-03-10T06:30:49-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1140859/000110465925021947/0001104659-25-021947-index.htm",
            "accession_number": "0001104659-25-021947",
            "summary_points": [
                "1. Cencora, Inc. raised its fiscal year 2025 adjusted diluted earnings per share (EPS) guidance from $15.25 to $15.55 to $15.30 to $15.60, as of March 10, 2025, citing continued momentum in its core U.S. Healthcare Solutions segment.",
                "2. This updated guidance, released on March 10, 2025, does not reflect any change in expectations for the recently completed acquisition of Retina Consultants of America.",
                "3.  The company's  March 10, 2025 filing states that a reconciliation of the non-GAAP financial measure to the most comparable GAAP financial measure is not provided on a forward-looking basis due to the difficulty of accurately estimating reconciling items."
            ]
        }
    ]
}